EGFR and EGFRvIII in Glioblastoma: Partners in Crime
Authors:
- Krishna P.L. BhatKBKrishna P.L. Bhat
- Kenneth AldapeKAKenneth Aldape
- 1 October 2013
- journal article
- editorial
- Published by Elsevier in Cancer Cell
- Vol. 24 (4) , 403-404
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- EGFR Phosphorylates Tumor-Derived EGFRvIII Driving STAT3/5 and Progression in GlioblastomaCancer Cell, 2013
- Nonreceptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3Cancer Cell, 2011
- Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastomaGenes & Development, 2010
- Identification of a PTEN-regulated STAT3 brain tumor suppressor pathwayGenes & Development, 2008
- The tumor-specific de2–7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFROncogene, 2004
- Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalizationProceedings of the National Academy of Sciences, 2003
- A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.Proceedings of the National Academy of Sciences, 1994